Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM
Clinical trial NCT07020949 · COMPLETED
Trial details
- NCT number
- NCT07020949
- Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-13
- Primary completion
- 2024-11-27
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.